Kirkland & Ellis advised Gainsight on the transaction and Wilson Sonsini Goodrich & Rosati advised Skilljar. Gainsight, a world-leading Customer Success platform that helps business drive...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Esperto on the transaction. Esperto Medical™ (Esperto), a healthtech start-up specializing in critical care and remote patient monitoring, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Evercore, who served as financial adviser to HTC, on this transaction. HTC Corp. (TWSE: 2498) and Google announced a definitive...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction, and Cooley advised Accolade. Transcarent, the “One Place for Health and Care,” and Accolade, a leader...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal counsel to Aadi. McDermott Will & Emery LLP is serving as legal counsel to Kaken. Cooley...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Grammarly in the transaction. Grammarly, the trusted AI assistant, announced its intent to acquire productivity platform Coda, with Coda’s CEO...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Syxsense on the transaction. Absolute Security, announced it acquired Syxsense, a provider of automated endpoint and vulnerability management. Financial terms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Entrata in the transaction, and Goldfarb Gross Seligman represented Colleen AI. Entrata®, a leading AI-enabled multifamily Operating System (OS), announced...
You must be a Standard 1 Year member to access this content.
